Viewing Study NCT00846859


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2025-12-29 @ 6:54 AM
Study NCT ID: NCT00846859
Status: COMPLETED
Last Update Posted: 2011-07-21
First Post: 2009-02-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?
Sponsor: Sahlgrenska University Hospital
Organization:

Study Overview

Official Title: Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?
Status: COMPLETED
Status Verified Date: 2011-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of the present clinical trial is to investigate whether 14 weeks of treatment with a prescription medication for smoking cessation (European trade name: Champix(R); US trade name: Chantix(R)), can reduce alcohol consumption in alcohol dependent individuals.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: